Evidencia científica
Estudios revisados por pares sobre suplementación
Indexamos automáticamente los estudios más recientes publicados en PubMed (NCBI / US National Library of Medicine). Filtra por tema o explora la evidencia más reciente.
-
Omega 3 (EPA/DHA)
Comparative Effectiveness of Nutritional Strategies for Sarcopenia-Related Outcomes in Older Adults: A Systematic Review and Network Meta-Analysis
Nutrients · 2026
Objective: This study compared the relative effects of distinct nutritional strategies on muscle mass, muscle strength, and physical performance in older adults with sarcopenia or at…
-
Omega 3 (EPA/DHA)
The Relative Bioavailability of Lutein and Zeaxanthin in the Presence of Omega-3 Supplements and Their Effect on Oxidative Stress Levels in Humans: A Pilot Study
Nutrients · 2026
Introduction: Lutein+Zeaxanthin (L+Z) are the major constituents of macular pigments of the retina. There is a lack of information on the bioavailability of the two compounds…
-
Omega 3 (EPA/DHA)
The effects of different forms of omega-3 polyunsaturated fatty acids on dry eye disease resulting from various etiologies: a meta-analysis and systematic review
BMC ophthalmology · 2026
BACKGROUND: To compare the therapeutic effects of omega-3 polyunsaturated fatty acids (PUFAs) supplements across different formulations and dry eye disease (DED) etiologies. METHODS: Studies were systematically…
-
Omega 3 (EPA/DHA)
Metabolomic Lipid Profile Changes in Patients with Heart Failure Undergoing Oral Nutritional Supplements Enriched with the Omega-3 (n-3) Polyunsaturated Fatty Acids and Mediterranean Diet
Nutrients · 2026
OBJECTIVE: Our objective was to analyze the specific effects of a MD plus omega-3-enriched oral nutritional supplements (MD+ONS) versus MD alone on the metabolic lipid profile…
-
Omega 3 (EPA/DHA)
Effect of omega-3 supplementation vs. placebo on blood lipid levels in patients with ischemic heart disease: a systematic review and meta-analysis
Nutrition, metabolism, and cardiovascular diseases : NMCD · 2026
BACKGROUND AND AIM: Residual dyslipidemia persists in ischemic heart disease (IHD) patients despite statins. Omega-3 fatty acids may help, but their precise lipid effects and clinical…
-
Omega 3 (EPA/DHA)
La suplementación combinada de polvo de algas protegido ruminalmente y colina protegida ruminalmente aumenta el contenido de ácido docosahexaenoico en la leche de cabra
Foods (Basel, Switzerland) · 2026
Antecedentes: La suplementación con RPC ha mostrado aumentar las concentraciones de VLDL y triglicéridos en suero, y la lipidómica ha revelado un incremento en los triglicéridos…
-
Omega 3 (EPA/DHA)
Krill oil increases plasma omega-3 fatty acids more than fish oil in healthy adults: a double-blind randomized controlled trial
The American journal of clinical nutrition · 2026
BACKGROUND: Omega-3 fatty acids (ω-3 FAs), particularly EPA and DHA, are recognized for their health benefits. However, their circulating levels after supplementation may be modulated by…